AI assistant
Syndax Pharmaceuticals Inc — Director's Dealing 2021
Nov 4, 2021
31977_dirs_2021-11-04_a15514af-7d15-406c-a38f-419f010f37b3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Syndax Pharmaceuticals Inc (SNDX)
CIK: 0001395937
Period of Report: 2021-10-22
Reporting Person: Nolte Alexander (N/A)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Options (Right to buy) | $21.36 | 2031-02-03 | Common Stock (62000.00) | Direct | |
| Stock Options (Right to buy) | $19.36 | 2031-09-15 | Common Stock (35000.00) | Direct | |
| Stock Options (Right to buy) | $18.03 | 2030-05-08 | Common Stock (5000.00) | Direct | |
| Stock Options (Right to buy) | $9.63 | 2028-02-08 | Common Stock (2000.00) | Direct | |
| Stock Options (Right to buy) | $9.47 | 2030-02-12 | Common Stock (16000.00) | Direct | |
| Stock Options (Right to buy) | $9.24 | 2027-05-01 | Common Stock (11667.00) | Direct | |
| Stock Options (Right to buy) | $9.00 | 2029-07-26 | Common Stock (7000.00) | Direct | |
| Stock Options (Right to buy) | $6.38 | 2029-02-06 | Common Stock (18000.00) | Direct |
Footnotes
F1: One forty-eighth (1/48th) of the total number of shares underlying the option vest monthly thereafter on the last day of each month, beginning February 28, 2021, subject to the reporting person's continuous service on the relevant vesting dates.
F2: One forty-eighth (1/48th) of the total number of shares underlying the option vest monthly thereafter on the last day of each month, beginning September 30, 2021, subject to the reporting person's continuous service on the relevant vesting dates.
F3: One forty-eighth (1/48th) of the total number of shares underlying the option vest monthly thereafter on the last day of each month, beginning May 31, 2020, subject to the reporting person's continuous service on the relevant vesting dates.
F4: One forty-eighth (1/48th) of the total number of shares underlying the option vest monthly thereafter on the last day of each month, beginning February 28, 2018, subject to the reporting person's continuous service on the relevant vesting dates.
F5: One forty-eighth (1/48th) of the total number of shares underlying the option vest monthly thereafter on the last day of each month, beginning February 29, 2020, subject to the reporting person's continuous service on the relevant vesting dates.
F6: Twenty-five percent (25%) of the total number of shares underlying the option vested on May 1, 2018, and one forty-eighth (1/48th) of the total number of shares underlying the option vest monthly thereafter on the last day of each month, subject to the reporting person's continuous service on the relevant vesting dates.
F7: One forty-eighth (1/48th) of the total number of shares underlying the option vest monthly thereafter on the last day of each month, beginning July 31, 2019, subject to the reporting person's continuous service on the relevant vesting dates.
F8: One forty-eighth (1/48th) of the total number of shares underlying the option vest monthly thereafter on the last day of each month, beginning February 28, 2019, subject to the reporting person's continuous service on the relevant vesting dates.